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ABSTRACT 
Objective: To evaluate unsupervised clustering methods for identifying individual-level 
behavioral-clinical phenotypes that relate personal biomarkers and behavioral traits in type 2 
diabetes (T2DM) self-monitoring data. 
Materials and Methods: We used hierarchical clustering (HC) to identify groups of meals with 
similar nutrition and glycemic impact for 6 individuals with T2DM who collected self-monitoring 
data. We evaluated clusters on: 1) correspondence to gold standards generated by certified 
diabetes educators (CDEs) for 3 participants; 2) face validity, rated by CDEs, and 3) impact on 
CDEs’ ability to identify patterns for another 3 participants.  
Results: Gold standard (GS) included 9 patterns across 3 participants. Of these, all 9 were re-
discovered using HC: 4 GS patterns were consistent with patterns identified by HC (over 50% of 
meals in a cluster followed the pattern); another 5 were included as sub-groups in broader clusers. 
50% (9/18) of clusters were rated over 3 on 5-point Likert scale for validity, significance, and 
being actionable. After reviewing clusters, CDEs identified patterns that were more consistent 
with data (70% reduction in contradictions between patterns and participants’ records).  
Discussion: Hierarchical clustering of blood glucose and macronutrient consumption appears 
suitable for discovering behavioral-clinical phenotypes in T2DM. Most clusters corresponded to 
gold standard and were rated positively by CDEs for face validity. Cluster visualizations helped 
CDEs identify more robust patterns in nutrition and glycemic impact, creating new possibilities 
for visual analytic solutions. 
Conclusion: Machine learning methods can use diabetes self-monitoring data to create 
personalized behavioral-clinical phenotypes, which may prove useful for delivering personalized 
medicine. 
  
BACKGROUND AND SIGNIFICANCE 
Chronic disease rates are growing worldwide, making improvements in chronic disease self- 
management a priority (1). Type 2 diabetes is one of the most prevalent and costly chronic 
diseases (2); self-management can reduce diabetes-related complications (3,4). However, recent 
studies demonstrated that individuals have unique glycemic responses to nutrition that depend on 
complex physiological and contextual factors (5,6). Indeed, it is now acknowledged that 
successful diabetes treatment and self-management should be tailored to individuals’ behaviors as 
well as their physiology (3,4). Self-monitoring data can be leveraged to personalize self-
management strategies; yet, further research is needed to achieve robust personalization (7). 
In recent years, phenotyping has become a popular approach to personalizing medical treatment 
to individuals’ genetic profile and clinical history. The concept of a phenotype was first 
introduced to contrast biological traits with their heritability (the genotype) (8,9). More recently, 
the term has expanded to represent collections of macroscopic observables, not necessarily 
anchored to a genotype, whose groupings illuminate patterns relevant for understanding human 
health (10–14).  
Phenotyping with clinical data from electronic health records (EHRs) is an area of active 
investigation (12,14–18). In this context, phenotyping is used to identify clinical patterns that 
motivate intervention (12,14,15), as well as identify diseases and improve clinical trial 
recruitment (16,17); it also holds promise for personalizing medical treatments (19,20). Machine 
learning techniques, such as hierarchical clustering, logistic regression, and neural networks, in 
conjunction with knowledge engineering approaches, have been used to computationally identify 
clinical phenotypes (12,15,18,19,21–23). 
However, phenotyping approaches can be applied to any macroscopic observable, including 
behavioral data, which can have special relevance to chronic disease self-management. For 
example, behavioral phenotypes have been used to describe manifestations of psychiatric 
disorders (e.g. “a behavioral phenotype is the characteristic cognitive, personality, behavioral, and 
psychiatric pattern that typifies a disorder” (24)) and to describe eating behaviors, including 
emotional eating (25) and fat consumption (26–28).  
We investigated the feasibility of applying phenotyping techniques to diabetes-related self-
monitoring data as a mechanism for personalizing self-management. We examined whether 
hierarchical clustering, which has proven useful in clinical phenotype construction (29), can 
identify meaningful relationships between modifiable characteristics of self-management 
behaviors, for example, inclusion of different macronutrients in an individual’s meals, and 
diabetes-specific biomarkers, like postprandial glycemic response (glucose dynamics that occur 
shortly after nutritional intake). However, our methods have three important distinctions from 
previous phenotyping efforts. 
First, we adopted a particular definition for the term phenotype. Previous literature suggests two 
different ways to conceptualize this phenomenon (11); 1) as the collection of macroscopic traits 
that define an individual’s current state; or 2) as a class of macroscopic trait collections; a disease 
is a phenotype because it embodies the collections of traits characteristic of individuals with a 
certain pathophysiological process. Both usages delineate individuals based on macroscopic 
characteristics, and both can be compatibly mathematized as probability densities over 
characteristics. However, the first usage is defined relative to an individual, whereas the second is 
defined relative to a population. We posit that during exploratory stages of phenotyping, it is 
essential to first identify and evaluate individual-level phenotypes (specific, scaled feature 
combinations), which can later form building blocks for general, population-level phenotypes. 
Consequently, we focus on characterizing traits within an individual, rather than focusing on 
population-wide phenomena.  
Second, unlike previous phenotyping studies that focused on either clinical, e.g. glucose 
measurements, or behavioral, e.g., consumption of macronutrients in meals, data, we examine 
integration of these distinct data types into hybrid behavioral-clinical phenotypes. This approach 
has the potential to: 1) help uncover complex and possibly reciprocal relationships between 
clinical and behavioral phenomena, 2) increase phenotype fidelity (30) , and 3) form an extensible 
framework for personalizing behavioral interventions focused on clinical goals.  
Third, we focus on discovering unnamed, poorly understood phenomena, rather than improving 
automatic discovery of known collections of traits, and, thus require different validation methods. 
Standard phenotyping studies are typically validated by some combination of the following steps: 
1) performing checks on face validity, or apparent reasonableness, of identified phenotypes, 2) 
assessing agreement with ground truth or “gold standard” (common in clinical domains), 3) 
correlating phenotypes to external variables with expected relationships to the phenotypes 
(common in behavioral domains), and 4) evaluating the internal phenotype consistency according 
to relevant criteria, like ratios between distances within and across phenotypes.  
Steps 3-4 are not appropriate here because they require specific hypotheses about relationships 
between variables, absent when phenotyping for personalized discovery. Step 2, gold standard 
comparison, presents new challenges in the context of self-monitoring data. In clinical 
phenotyping, gold standards typically focus on presence of a certain condition (binary), are easily 
expressed quantitatively, and are easily compared with computational phenotypes. In contrast, 
gold standards for self-management behaviors may involve complex observations and may be 
expressed qualitatively (e.g. “consuming less than 30% of calories from protein is associated with 
high glycemic impact”), making them difficult to mathematize for comparison to 
computationally-generated phenotypes. 
To bridge the gap between qualitative gold standards and quantitative analyses, we translate 
language-based gold standards into mathematical objects (Boolean expressions) and evaluate 
computed phenotypes against mathematized gold standards. We hypothesize that gold standard 
inadequacies can be addressed by evaluating mathematized versions for agreement with raw data, 
and contextualizing computational-phenotype evaluations with gold standard quality. We further 
hypothesize that expert face validity assessments can additionally compensate for gold standard 
incompleteness. 
This work aims to expand phenotype analyses to the chronic disease management context and 
outline a methodology for discovering and evaluating unique, personal patterns that elucidate 
relationships between dietary patterns and glycemic responses in people with type 2 diabetes. 
This work was guided by four research questions: 1) How can automated phenotyping techniques 
be used to discover systematic, clinically meaningful trends in self-monitoring data? 2) What 
feature sets should be selected for phenotype construction from diabetes self-monitoring data? 3) 
How can behavioral-clinical phenotypes be evaluated and validated empirically? 4) Can 
behavioral-clinical phenotypes be used to help clinicians better understand patterns in self-
monitoring data? By answering these questions, we both define the methodology and work 
toward improving chronic disease management. 
METHODS 
1. Data collection and pre-processing 
1.1 Participants and data collection 
Data were collected from 6 adults with type 2 diabetes recruited from a popular diabetes online 
community using advertisement on the community’s website. During the study, participants 
recorded photo and text-based descriptions of each meal and its ingredients, along with BG 
measurements before and 1-3 hours after the meal using a custom smartphone app. The study was 
approved by the Columbia University Medical Center Institutional Review Board (IRB); all 
participants digitally signed an informed consent before starting the study.  
1.2 Nutrition estimation 
After the data collection study, each meal was randomly assigned to one of five registered 
dietitians (RDs) for evaluation of its macronutrient content. The RDs used each meal’s image and 
textual description to estimate ingredient quantities, and used the USDA National Nutrient 
Database (https://ndb.nal.usda.gov/ndb/search/list) to determine macronutrient (carbohydrate, 
fiber, protein, and fat) and calorie composition of each meal.  
2. Phenotype Identification and Definition 
2.1 Defining the Feature Set for Automatic Phenotyping Methods 
We worked with two Certified Diabetes Educators (CDEs), with over 40 years of combined 
clinical and nutritional experience, to identify appropriate features for representing behavioral-
clinical phenotypes in diabetes self-monitoring data, including macronutrients in each meal and 
glycemic impact of each meal. This led to four candidate features sets: 1) percent calories of 
macronutrients (no BG), 2) grams of macronutrients (no BG), 3) BG impact with percent calories 
of macronutrients, and 4) BG impact with grams of macronutrients. 
2.2 Automated Phenotype Estimation 
We used hierarchical clustering to group each participant’s meals by their similarity along the 
selected features (1-4 feature sets above). Hierarchical clustering was selected for its flexibility 
with respect to distance metric, its ability to detect non-linear and aspherical patterns, its 
production of hierarchical similarities that remove the need for a prior fixed cluster numbers, and 
its previous use history in phenotyping studies (31,32). We performed hierarchical clustering 
using the “hclust” function in R with min-max scaling (to achieve balanced feature scaling with 
few assumptions on the data distribution), Euclidean distance metric (since we had sufficiently 
low dimensional continuous variables), and mean linkage criterion (to view each cluster as 
representing a mean or prototypical meal). Hierarchical clusters were split according to the 
number of clusters that maximized the Calinski-Harabasz (CH) criterion, a ratio between variance 
across and within clusters (33). Clusters with fewer than 5 meals were discarded, due to low 
statistical power and CDEs’ recommendations. 
3. Phenotype Evaluation 
We evaluated phenotypes by: 1) comparing with expert-generated gold standards, and 2) 
assessing face validity. In addition, we examined the impact of phenotypes on experts’ ability to 
assess and understand self-monitoring data.  
3.1 Gold Standard Comparison 
In order to leverage qualitative gold standards for evaluating computationally-generated 
behavioral-clinical phenotypes, we performed the following steps: a) generated qualitative gold 
standards, b) translated the gold standards into computable formats that can be quantitatively 
evaluated and compared to, c) quantified gold standard quality and correspondence to data, d) 
selected cluster variables, and e) quantitatively evaluated the degree to which automatic 
phenotyping rediscovered gold standards. 
3.1.a Qualitative Gold Standard Generation 
To develop gold standards for evaluation, each CDE first worked independently to identify 
patterns in the self-monitoring datasets, which were formatted into spreadsheets of their 
specification (features of each individual meal with summary statistics), then CDEs worked 
together to develop a consensus. Finally, they worked with the research team to ensure their 
observations used precise language suitable for translation into compound inequality expressions.  
For the first three datasets (P1-P3), gold standards were developed twice. The first set was based 
only on raw data; these gold standards were used for quantitative phenotype evaluation. The 
second set was developed after CDEs examined both raw data and visualizations from automatic 
phenotype discovery (parallel coordinate plots of cluster means, (Figure 3)); these gold standards 
were used to assess how phenotype discovery can influence CDEs’ understanding of data. For the 
remaining datasets (P4-P6), gold standards were created only once, with access to both raw data 
and phenotype visualizations; these gold standards were also used to assess how phenotype 
discovery can influence CDEs’ understanding of data. 
3.1.b Translating the Written Gold Standard to Computable Inequalities  
We converted expert-generated patterns into compound inequalities. For example, the 
observation, “Lunch with greater than 45% of calories came from fat, the meals often had high 
excursion,” encodes three components: 1) lunch, 2) percent of calories from fat, and 3) 
postprandial glycemic increase greater than 50 mg/dl (according to CDEs’ definition of “high 
excursion”) and translates to: (meal type == “Lunch”) & (calories from fat > 45%) & (blood 
glucose change > 50 mg/dl). 
We then compared translated patterns to the raw data. In several cases when CDEs used ranges of 
macronutrients to specify patterns, the corresponding compound inequalities showed low 
correspondence with the data, often because of too narrow specification of ranges. In these cases, 
we conferred with the CDEs to discuss adjustments to pattern definitions. For example, one 
observation mapped to no meals when defined on a range of 30-40g of carbohydrates, but 
mapped to many meals when the carbohydrate range was widened to 25-45g. 
3.1.c Evaluation of the Expert Estimated Gold Standards 
Once we finalized the set of compound inequalities that represented CDEs’ consensus of clinical 
patterns in each dataset, we computed three simple criteria for evaluating gold standard quality: 
1) the fraction of all meals that support each inequality (met all conditions of the inequality, i.e. 
true positive rate), 2) the fraction of meals that contradict each inequality (met all conditions 
pertaining to nutrition, but violated conditions pertaining to glucose, i.e. false positive rate), and 
3) the total number of inequalities that over-fit the data and only apply to 1-2 meals. 
3.1.d Evaluation of Feature Selection 
To identify preferred feature sets for phenotype discovery, we compared gold standards to the 
clustering output from each of four candidate feature sets. To perform this comparison, we 
translated the gold standard compound inequalities into a partition of meals. We then 
quantitatively assessed similarity between discovered partitions and translated gold standard 
partitions using the Adjusted Rand index (ARI), which quantifies the similarity of partitions, 
adjusted for chance element placement (34,35). We used an online tool (36) to compute ARI and 
estimate its 95% confidence interval (37). We selected the feature set that most often maximized 
ARI for downstream quantitative analysis of phenotype discovery. 
3.1.e Evaluation of Automatically Estimated Phenotypes Against the Gold Standard 
We compared phenotypes to the gold standard for P1-3 generated by CDEs using only raw self-
monitoring data using two different metrics. 
First, we identified clusters that likely contained enough information to rediscover each gold 
standard observation, specifically, observations whose meals comprise at least 50% of a single 
cluster. We used the number of rediscovered whole-phenotype observations, and the fraction of 
meals accounted for in this way, to evaluate the degree to which hierarchical clustering can be 
used to automatically rediscover clinical patterns in self-monitoring data. 
Second, we identified clusters that likely represented a special case of a more general pattern 
identified by CDEs. These rediscovered partial phenotype observations were defined as cases 
when >50% of meals from the observation belong to the cluster. This provided an indication of 
how similarly the algorithm split the data compared to expert observations. 
3.2 Face Validity 
In order to evaluate face validity of the identified phenotypes, CDEs were shown visualizations of 
clustering results (parallel coordinate plots of cluster means, (Figure 3)), along with raw self-
monitoring data. They were shown two versions of clustering results from two feature sets (blood 
glucose change with grams of macronutrients and blood glucose with percent calories from 
macronutrients). CDEs first identified the preferable feature set for the given dataset based on two 
sets of output, then rated each cluster in the preferred output from 1-5 (1: not-at-all, 5: absolutely) 
in terms of whether the cluster was: 1) valid based on the data, 2) clinically significant, and 3) 
actionable; they also provided a rationale for their responses. 
In order to specifically evaluate our ability to uncover hard-to-detect phenotypes, we separately 
reported face validity metrics for clusters that did not align with any gold standard observations. 
3.3 Evaluation of the Impact of Automatically Estimated Phenotypes on Expert Analysis 
In order to evaluate whether results from automatic phenotyping can support CDEs’ ability to 
understand and analyze diabetes self-monitoring data, CDEs generated new gold standards using 
both the raw self-monitoring data and visualizations of clustering results (parallel coordinate plots 
of cluster means, (Figure 3)). For P4-6 datasets, this approach was used upon the CDEs’ first data 
viewing; for P1-3, this was done after an original gold standard was created using only raw data. 
We used our three gold standard quality metrics (fractions of meals that support, contradict, and 
over-fit the gold standard observations) to compare the quality of gold standards generated with 
and without phenotype visualizations. 
RESULTS 
Self-monitoring data collected from six individuals is summarized in Table 1. Figure 1 illustrates 
the unique behavioral-clinical patterns in individuals’ data. 
4. Automatic Phenotype Identification 
Figure 2a-b depicts the results from hierarchical clustering of nutritional content of meals from 
the P2 and P3 dataset using the grams of macronutrients feature set. Some trends are readily 
visible (e.g. for P2, low carbs and low fiber align with smallest glucose increases). Figure 2c-d 
show the Calinski-Harabasz optima, which was used to select an appropriate number of clusters; 
for P2 (fig. 2b), 10 clusters were selected, and clusters with fewer than 5 meals were discarded, 
leaving 4 analyzed clusters. The resulting clusters for P2 and P3 are summarized in figure 3 by 
showing parallel coordinate plots of each cluster mean, and all cluster summaries are provided in 
supplementary figure 2. 
5. Phenotype Evaluation 
5.1 Gold Standard Comparison 
5.1.a-b Gold standard creation and translation 
CDEs generated 23 total observations across three participants (12 for P1, 7 for P2, and 4 for P3, 
see Tables 1-3 in supplementary materials). Fourteen observations were excluded from analysis, 
because they described nutrition or glucose, but not both jointly (7 in P1, 1 in P2, 2 in P3) or 
because they specified unanalyzed variables, including time between meals and specific 
ingredients (3 in P1, 1 in P2), leaving nine gold standard observations for analysis in P1-3. Of 
these, six specified meal-type and six specified more than 1 macronutrient. Carbohydrate was the 
most frequently specified macronutrient (5/9) and fiber the least (2/9). Observations were 
translated into Boolean queries (supplementary tables 1-3). 
5.1.c Evaluation of the Expert Estimated Gold Standards 
Of the nine analyzed observations, two were over-fit (only fit 1 meal; 1 in P2, 1 in P3), and two 
were contradicted by the data more often than they were supported (1 in P2, 1 in P3). For 
example, P3 observation three states ”higher inclusion of fat (over 40%) leads to high excursion” 
and fits with 30% of P3’s meals. However, 50% of P3’s meals are meals with more than 40% fat 
and low glycemic excursions under 50 mg/dl. Observation redundancy was also observed (e.g. 
observation 6 in P2 subsumes 85% of observation 2). The remaining observations were generally 
consistent with the data (supported more often than contradicted) and presented good coverage 
(over 10% of the meals in the corresponding datasets). Five observations (22%) initially fit zero 
meals, but iterative adjustments substantially improved their fit with the data. Table 2 summarizes 
gold standard observation quality; supplementary tables 1-3 contain the raw observations, their 
Boolean translations, and their evaluation statistics. 
5.1.d Evaluation of Feature Selection 
We evaluated similarity between gold standard partitions and clusters of P1-3 using the adjusted 
Rand Index (ARI) (Table 3). Clustering with “BG with grams of macronutrients” feature set 
maximized ARI for two of three participants (P1 and P3), and was second-best for P2. 
5.1.e Evaluation of Automatically Estimated Phenotypes Against the Gold Standard 
Comparisons of automatically generated clusters (using ARI-selected feature set) with CDE-
generated observations (“observations” refer to the gold standards) showed that five of nine total 
observations were rediscovered as whole-phenotypes through clustering (comprised at least 50% 
of meals in a cluster) (1 in P1, 4 in P2). The four remaining observations that comprised minority 
portions of clusters exhibited poor correspondence with the data—they either represented less 
than 10% of the data or were frequently contradicted. However, all low-frequency CDE-
observations were rediscovered as partial phenotypes, or sub-clusters of our phenotypes. For 
example, 100% of observation of eight meals in P3 were placed into cluster two. Two of the 
remaining observations were trivially sub-clustered (each corresponded to a one-meal sub-
cluster). All results are reported in Supplementary Tables 4-6. 
5.2 Face Validity 
5.2.1 Evaluation of Expert-based Face Validity of Automatic Phenotyping 
Table 4 reports and summarizes CDEs’ phenotype face validity survey responses. Overall, the 
CDEs rated 50% (9 of 18) of identified clusters over three (on a 1-5 Likert scale) for validity, 
significance, and being actionable. Four of the nine remaining lower-rated clusters lacked 
meaning and contained mostly noise—they scored below three in all three categories, and did not 
align with any CDE observations. Three clusters scored very highly on validity, but lacked 
clinical significance; one was found not actionable, and one lacked clinical significance. The 
primary reason for low-scoring clusters was high within-cluster variance of blood glucose or 
macronutrients. Clusters that grouped meals with moderate glycemic impact (20-50 mg/dl 
change) were typically considered not actionable and lacking clinical significance. 
5.2.2 Evaluation of Automatically Estimated Novel Phenotypes: 
While all nine analyzed gold standard observations from P1-3 datasets were rediscovered as 
either partial or whole phenotypes, we also assessed the five novel clusters that did not align with 
any gold standard observation and may contain valuable information missing from the gold 
standard. 
Two of five novel clusters were rated three or above on a five-point Likert scale in all three 
categories of validity, indicating their reasonableness as novel discoveries. Three novel clusters 
(one in P2, two in P6) received low face validity scores, and were described as having low 
validity based on the data, not clinically significant, and not actionable.  
5.3 Evaluation of the Impact of Automatically Estimated Phenotypes on Expert Analysis 
Table 2 shows that observations generated with cluster visualizations (P4-6, reported in 
supplementary tables 7-9) were supported by fewer total meals than those generated with only 
raw data (P1-3), but were contradicted by the data less frequently. Two of the seven analyzed 
observations were over-fit (2 in P4), and only 1 observation was contradicted more often than it 
was supported. Table 2 also shows that observations generated with cluster visualizations were 
supported by fewer meals in P1 and P2 but reduced the contradiction rate by over 70% for P2 and 
P3 (details in supplementary tables 7-9). 
DISCUSSION 
In this study, we applied phenotyping methods to the context of personal health data and diabetes 
self-management. Our research questions focused on applicability of the phenotyping techniques 
to self-monitoring data, appropriate feature sets, appropriate methods for validating such 
phenotypes, and their impact on CDEs’ ability to better understand patterns in patients’ data. 
Overall, we found that 50% (9 out of 18) of clusters discovered using hierarchical clustering had 
high correspondence with the gold standard; moreover, this approach reproduced five of nine 
CDE-generated observations, and identified generalizations of the remaining four observations. 
Given the large volume of possible partitions of the datasets used in this study, this indicates a 
substantial correspondence between the phenotypes and the gold standards. These results suggest 
that clustering approaches can serve as building blocks for establishing individual- and, possibly, 
population-level behavioral-clinical phenotypes, and may form important analytical structures in 
behavioral informatics interventions. Moreover, more than half of all clusters received high 
ratings for being clinically valid, significant, and actionable. This suggests that such clusters have 
the potential to provide useful assistance in identifying significant traits in patients’ self-
management behaviors, which could be used to personalize their self-management strategies. 
In regards to the feature set selection, we found that including blood glucose with grams of 
macronutrients most often optimized the ARI partition similarity metric. This was partially 
consistent with perceptions of CDEs, who suggested including glycemic impact as a clustering 
variable. However, these findings contradicted their expectation that proportion of calories 
contributed by macronutrients better explains nutritional-glycemic trends than absolute 
macronutrient weights. This finding suggests that including health biomarkers as part of 
clustering is a fruitful alternative to clustering on either behaviors (nutrition) or clinical outcomes, 
as was done in previous efforts to phenotype behaviors (13). It also indicates a potential need for 
healthcare professionals to select different clustering features on a case-by-case basis. 
Moreover, the study suggested that exposing CDEs to computationally generated clusters led 
them to generate observations with higher specificity and lower sensitivity (i.e. the CDEs gave a 
more conservative account of patterns present in the data). When viewing phenotype 
visualizations, CDEs identified fewer patterns overall, and accounted for fewer meals in their 
observations (reduced sensitivity); however, each pattern was contradicted less often and 
typically had more support from the data (higher specificity).  
At the same time, this study identified open questions in regards to applying computational 
approaches to discovering behavioral-clinical phenotypes. For example, evaluation of such 
phenotypes through a gold-standard validation pipeline presented considerable difficulties and 
necessitated modifying traditional evaluation approaches. The availability of gold standards was 
vital to our evaluation, as they imposed a domain-specific quality metric and allowed for scalable 
model selection. Because gold standards for behavioral-clinical phenotypes predominantly exist 
as qualitative expert knowledge, innovations were necessary to bridge the gap between the 
qualitative and quantitative descriptions of identified patterns. Additional methods were 
necessary for assessing gold standard quality and contextualizing their comparisons. Our findings 
suggest that further innovations, beyond manual, iterative translation of qualitative statements 
into quantitative expressions, are necessary for efficient, reliable use of gold standards for 
validating complex, unnamed phenomena. While validation with an imperfect gold standard 
poses fundamental limitations, prospective validation experiments, including n=1-trials and self-
experimentation framework (38,39), and other task-based validity approaches may be better 
suited to validating behavioral-clinical phenotypes. 
In addition, while this study suggested that computational methods used in traditional 
phenotyping research can be applied to non-clinical data in order to identify behavioral-clinical 
phenotypes, questions remain as to how these phenotypes can be used for personalizing self-
management strategies. Moreover, further research is needed to identify appropriate ways to 
design new informatics interventions that use personalized self-management strategies to help 
individuals with chronic conditions improve their health.  
LIMITATIONS 
Our cohort included 6 people; these results may not be generalized to all people with type 2 
diabetes. Moreover, most participants were well controlled with self-reported HbA1c values 
around 6% and exhibited low variance in nutritional intake; the method may generalize 
differently in patients with less controlled diabetes, or with greater variability in nutritional 
intake. Definitions for rediscovered whole and sub-phenotype patterns were chosen as simple 
heuristics, and are not complete assessments of correspondence between gold standard and 
automatic clusters. In general, comparison becomes difficult when the gold standard is not a true 
partition (contains multiple mappings and null mappings). Nevertheless, these metrics provide 
first-order approximations of similarity. 
CONCLUSION 
We have developed an implementation of hierarchical clustering and an evaluation methodology 
for identifying and validating clinically meaningful behavioral-clinical structures and the features 
used to define them from diabetes self-monitoring data. The evaluated phenotyping approach and 
its population-level successors create exciting opportunities to support individuals in exploring 
and improving their health. Our long-term vision is to use self-monitoring data to uncover 
important behavioral-clinical phenotypes that can shed light on treatment practices and help 
identify specific, personalized self-management strategies. In this way, behavioral-clinical 
phenotyping can form the analytical backbone for informatics interventions that take a holistic, 
data-driven approach to personalized medicine. 
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FIGURES 
a) 
 
b) 
 
Figure 1: Parallel coordinate plots of behavioral-clinical self-monitoring data from P2-P3. Each 
line represents a single meal, and each vertical axis represents a behavioral or clinical variable 
(labeled at the bottom of each plot). The line color indicates the degree of glucose change, where 
red is highest and blue is lowest. These plots demonstrate the heterogeneity of behavioral-clinical 
patterns within and across participants. 
  
a)      c) 
 
b)      d) 
 
Figure 2: Raw clustering analysis for P2-P3. In figures (a) and (b), we show heatmaps of 
normalized behavioral-clinical variables for P2 and P3, where each row represents a meal. The 
data are max-min normalized by each column, so that the darkest row in a column represents the 
meal with the largest value in that column. The dendrogram tree on the left axis indicates the 
hierarchical similarities between groups of meals. The blocked sections of the dendrogram 
indicate how the tree is cut when selecting a particular number of clusters (for P2, 11; for P3, 2). 
In figures (c) and (d), we plot the Calinski-Harabasz (CH) criterion for 1-12 clusters, and find it 
takes a maximum at 11 clusters for P2 and at 2 for P3, indicating an advantageous balance 
between internal consistency of clusters and their dissimilarity from each other. The CH criterion 
is related to the ratio of average between- and within-cluster sums of squared distances, both of 
which we plot for comparison. Note that both within-cluster and between-cluster variance 
saturates as cluster number increases. As expected, within-cluster variance decreases and 
between-cluster variance increases as cluster number increases.  
  
a) 
 
b) 
 
Figure 3: Parallel coordinate plots of cluster means from P2 (a) and P3 (b). Each line represents 
the mean values for a single cluster. Clustering was performed using the blood glucose with 
grams of macronutrients feature set, and clusters with fewer than 5 meals were excluded. We 
observe that each participant exhibits different personal behavioral-clinical phenotypes. P2 
clearly has a group of meals with moderate-high glycemic impact that are high in protein and fat 
(red). P3 shows a phenotype where lower carbohydrates, in conjunction with lower fiber, protein, 
and fat lead to higher glycemic impacts. Note that CDEs were shown similar visualizations when 
generating gold standards, but they received more detailed plots with additional axes to indicate 
other variables they were interested in.  
TABLES 
 
Table 1: Participant Self-Monitoring Data Description 
  
Participant ID  P1  P2  P3  P4  P5  P6  
Age  40−50  40−50  40-50 50-60 50-60  50-60 
Disease Status  T2D  T2D  T2D  T2D  T2D  T2D  
Diabetes Medications  Oral agents  Oral agents None Oral 
agents 
Oral 
agents 
Insulin, 
oral 
agents 
# of glucose measurements  304  211  89  118  86  70  
# of meals recorded  120  76  45  60  48  36  
# of meals with associated pre- and post-
meal glucose  
101  72  44  56  40  34  
# of days measured  27  28  51  36  32  21  
Mean measured glucose (mg/dL) 113±25  127±32  192 ± 65  113±16  97±19  121 ± 31  
Mean measured pre-meal glucose (mg/dL) 97±15  111±25  169 ± 57  105±9  87±11  111 ± 21  
Mean measured post-meal glucose(mg/dL)  126±26  139±32  214 ± 65  124±16  110±19  132 ± 36  
  
Table 2: Here, we summarize our evaluation of gold standard quality. We have 1 row for each 
gold standard, and P1-3 appear twice because they were each evaluated twice separately using 
different source data (raw self-monitoring data refers to excel spreadsheets made to CDEs’ 
specifications, “cluster-vis” refers to parallel coordinate plots of cluster means (c.f. Figure 3). The 
number of over-fit and contradictory gold standard observations provide a measure of over-
generalization and inconsistency with the data, respectively. The fraction of meals supported and 
contradicted by the gold standard observations indicates the overall rates of true positives and 
false negatives in the gold standard. 
 
Particip
ant ID 
Data available 
during gold 
standard 
generation 
Number of 
analyzed 
expert 
observations 
Number of 
over-fit 
observations 
Number of 
contradictory 
observations 
% meals 
supported by 
observations 
% meals 
contradicted by 
observations 
P1 
Raw self-
monitoring 
2 0 0 31% 7% 
P2 
Raw self-
monitoring 
5 1 1 74% 23% 
P3 
Raw self-
monitoring 
2 1 1 32% 52% 
P4 
Raw self-
monitoring & 
cluster-vis. 
4 2 1 27% 23% 
P5 
Raw self-
monitoring & 
cluster-vis. 
2 0 0 25% 13% 
P6 
Raw self-
monitoring & 
cluster-vis. 
1 0 0 29% 0% 
P1 
Raw self-
monitoring & 
cluster-vis. 
4 0 0 24% 14% 
P2 
Raw self-
monitoring & 
cluster-vis. 
2 0 0 43% 4% 
P3 
Raw self-
monitoring & 
cluster-vis. 
5 0 0 59% 14% 
  
Table 3: Similarity between gold standard observations and cluster results using different feature 
sets. Partition similarity based on Adjusted Rand Index (ARI) and its 95% confidence interval. 
Note that ARI ranges from 0-1, with 0 indicating no partition similarity and 1 indicating perfect 
partition similarity—higher ARI indicates greater similarity to gold standard. We note that ARI 
for P1 and P3 is maximized using the blood glucose and grams of macronutrients feature set. 
 
  
Partici
pant 
ID  
Grams of 
Macronutrients  
%-Calories from 
Macronutrients 
Blood Glucose & 
Grams of 
Macronutrients  
Blood Glucose & %-
Calories from 
Macronutrients 
P1 0.018 (0.000-0.232) 0.273 (0.128-0.408) 0.495 (0.215-0.763) 0.00 (0.00-0.00)  
P2 0.472 (0.225-0.735) 0.611 (0.373-0.870) 0.549 (0.307-0.810)  0.544 (0.319-0.779) 
P3 0.074 (0.000-0.253) 0.086 (0.000-0.324) 0.344 (0.000-1.000) 0.130 (0.000-0.471) 
  Valid (1-5) Significant (1-5) Actionable (1-5) CDEs’ feature 
preference 
P1 3.5 4 4 BG with 
Percent-calories 
from 
macronutrients 
3.5 4 4 
P2 3.75 4 4 BG with grams 
of 
macronutrients 3.5 3.5 4 
5 4 4 
2 2 1.5 
4 3.5 2 
P3 4 4 4 BG with 
Percent-calories 
from 
macronutrients 
4 3 4 
2 4 2 
P4 1 1 1 BG with 
Percent-calories 
from 
macronutrients 
4 2 2 
P5 1.5 1.5 1 BG with 
Percent-calories 
from 
macronutrients 
4 2.5 4 
4 4 3.5 
P6 1 1 1 BG with grams 
of 
macronutrients 4 4 4 
4 4 4 
1 1 1 
Total mean 3.14 3.0 2.89  
Table 4: Face validity Likert scores (on a scale of 1-5, strongly disagree to strongly agree). For 
each participant, CDEs were presented with clustering results from two different feature sets (BG 
with grams of macronutrients, BG with percent-calories from macronutrients), and CDEs selected 
which feature set’s results they preferred and would like to evaluate. They elected to evaluate BG 
with percent-calories from macronutrients for 4/6 participants even in cases where ARI indicated 
that the other feature set was more similar to their gold standard. 
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SUPPLEMENT 
 
Observatio
n #  Text Description  Boolean Query  
%-meals in 
agreement  
%-meals  with 
opposite 
glycemic impact  
8 
When breakfasts had 
higher proportion of 
carbohydrates (more than 
40%) and lower in protein 
(less than 40%), there is a 
higher differential (over 
100) in 1 hour  
Meal-type == ”Breakfast” 
calories-from-carbs > 35% 
calories-from-protein < 35% 
BG-change > 50  
10%  6%  
9  
Lunch: high inclusion of 
protein (over 55%) with 
generally mild glycemic 
impact  
Meal-type == ”Lunch” 
calories-from-protein > 55% 
BG-change < 50  
1%  0%  
9 revised-1   
Meal-type == ”Lunch” 
calories-from-protein > 30% 
BG-change < 50  
6%  0%  
9 revised-2  calories-from-protein > 30% BG-change < 50 22% 1% 
 TOTAL  32 
31% meals 
accounted 
for by 
observations  
7% meals 
contradict an 
observation 
Supplementary Table 1: P1 Gold Standard evaluation 
  
Supplementary Table 2: P2 Gold Standard evaluation   
Observati
on #  Text Description  Boolean Query 
%-meals in 
agreement  
%-meals  
with opposite 
glycemic 
impact  
2  
Moderate amount of carbohydrate (around 
30g-40g) combined with higher fiber 
(around 9-10g or higher) lead to more 
moderate impact (under 50)  
25g < carbs < 45g 
fiber > 8g 
BG-change < 50  
18%  11%  
3  
High carbohydrate meals (over 40g) that 
have more even inclusion of other 
macronutrients have more moderate 
impact (around 50 or below; particularly 
for dinner) but low certainty because only 
few cases  
carbs > 35g  
calories-from-carbs > 25% 
calories-from-protein > 25% 
calories-from-fat > 25% 
BG-change < 50  
1%  3%  
4 original 
Breakfast generally minimal excursion 
(carbs between 13 and 15, which is lower 
than for other types of meals because of 
the proportionately higher fiber, around 9g 
or higher, as compared to other meals)  
Meal-type == ”Breakfast” 
10g <carbs< 20g 
fiber > 8g 
BG-change < 50  
0% 0% 
4 revised 
Breakfast generally minimal excursion 
(carbs between 13 and 15, which is lower 
than for other types of meals because of 
the proportionately higher fiber, around 9g 
or higher, as compared to other meals)  
Meal-type == ”Breakfast” 
10g < carbs < 20g 
BG-change < 50  
25%  0%  
5  
Lunch when greater than 45% of calories 
came from fat, the meals often had high 
excursion  
Meal-type == ”Lunch” 
calories-from-fat> 45% 
BG-change > 50  
17%  10%  
6  
Dinner the lunch trend of high proportions 
does not hold. At dinner, similarly high 
proportions of fat and protein did not lead 
to high excursions, potentially because of 
higher fiber (10g and above), but low 
certainty because of variability  
Meal-type == ”Dinner” 
(calories-from-fat > 45% OR 
calories-from-protein > 45%) 
BG-change < 50  
29%  7%  
 TOTAL  53 
74% of 
meals 
accounted 
for by 
observation
s  
23% meals 
contradict an 
observation 
 Supplementary Table 3: P3 Gold Standard evaluation  
  
Obser
vation 
#  
Text Description  Boolean Query %-meals in agreement  
%-meals  
with opposite 
glycemic 
impact  
3  
Overall: higher inclusion of fat 
(over 40%) leads to high 
excursion  
calories-from-fat > 40% 
BG-change > 50  30%  52%  
4  
Dinner: higher carb (30%) and 
lower fat (under 40%) lead to 
low excursion  
Meal-type == ”Dinner” 
calories-from-carbs > 
30% 
calories-from-fat < 40% 
BG-change < 50  
2%  0%  
 TOTAL  14 
32% meals 
accounted 
for by 
observations  
52% of meals 
contradict an 
observation 
Supplementary Table 4: P1 Cluster-Gold-Standard alignment 
Note: “Observation” is abbreviated as “OBS” 
  
  % of a given cluster that satisfies:  
clusterID # of meals Any Observation OBS 3 OBS 4 OBS 5 
OBS 6 
1 6 50%   50%  
2 25 56% 56% 40%   
3 22 0%     
4 42 14%    14% 
 Supplementary Table 5: P2 Cluster-Gold-Standard alignment 
Note: “Observation” is abbreviated as “OBS” 
  
  % of a given cluster that satisfies:  
clusterID # of meals Any Observation OBS 2 OBS 3 OBS 4  OBS 5 OBS 6 
1 6 83% 67%    83% 
2 22 91%   81%  9% 
3 9 78%    78%  
5 9 11%    11%  
6 10 90% 50%   20% 60% 
  
 
 
 
 
 
 
 
Supplementary Table 6: P3 Cluster-Gold-Standard alignment 
Note: “Observation” is abbreviated as “OBS” 
  
  % of a given cluster that satisfies:  
clusterID # of meals 
Any 
Observation OBS 3 OBS 4 
1 14 21% 14% 7% 
2 30 37% 37%  
  
Observatio
n #  Text Description  Boolean Query 
%-meals in 
agreement  
%-meals  with 
opposite 
glycemic impact  
2  
The highest glycemic 
excursions come after 
breakfast  
mealType == ”Breakfast” 
BGchange > 80% − quantile  13%  5%  
3  
As carbohydrate 
content goes up (over 
22%), and fat goes up 
(over 40%) fiber 
content goes down 
(below 8g), which 
contributes to higher 
excursion  
calories-from-carbs > 22% 
calories-from-fat > 40% 
fiber < 8g 
BGchange > median−BGchange  
16%  11%  
5  
When fiber is 8g or 
above, and carbs are 
below 22% and fat is 
above 60% there is 
lower excursion  
fiber ≥ 8g 
calories-from-carbs < 22% 
calories-from-fat > 60% 
BGchange < median−BGchange  
2%  0%  
6  
Higher fat content in 
the morning (breakfast) 
is keeping BG 
excursion low despite 
lower fiber (below 8g)  
mealType == ”Breakfast” 
calories-from-fat > 40% 
fiber < 8g 
BGchange < median−BGchange  
2%  7%  
 TOTAL  15 
27% meals 
accounted 
for by 
observation
s  
23% of meals 
contradict an 
observation  
Supplementary Table 7: P4 Expert Observations 
  
Observatio
n #  Text Description  Boolean Query 
%-meals in 
agreement  
%-meals  
with opposite 
glycemic 
impact  
2  
For dinner meals, 
meals that have 40- 
60% fat have mild 
impact  
mealType == ”Dinner” 
40% < calories-from-fat < 60% 
BGchange < 50  
18%  13%  
3  
For breakfasts, meals 
that have over 40% 
of protein, and about 
35% of carbs have 
mild impact  
mealType == ”Breakfast” 
30% < calories-from-carbs < 
40% 
calories-from-protein > 40 
BGchange < 50  
8%  0%  
 TOTAL  10 
25% meals 
accounted 
for by 
observation
s 
13% of meals 
contradict an 
observation 
Supplementary Table 8: P5 Expert Observations 
  
 Observ
ation #  Text Description  Boolean Query 
%-meals in 
agreement  
%-meals  
with 
opposite 
glycemic 
impact  
4  
Minimum of 5g of fiber and 
fat content between 40%-
60% then BG impact < 50 
(based on cluster 4)  
fiber >= 5g 
35% < calories-from-fat < 65% 
BGchange < 50  
29%  0%  
 TOTAL  10  
29% meals 
accounted 
for by 
observation
s 
0% of 
meals 
contradict 
an 
observation 
Supplementary Table 9: P6 Expert Observations 
  
 Observati
on #  Text Description  Boolean Query 
%-meals in 
agreement  
%-meals  
with 
opposite 
glycemic 
impact  
3 
The majority of high 
impact meals are 
breakfasts (have the 
highest BG excursion and 
highest post-meal) 
Meal-Type == ”Breakfast” 
BG-change > 50  15% 11% 
4 original 
High carbohydrate (over 
40%) in breakfast meals, 
combined with low 
protein (20%) lead to 
high excursions 
BG-change > 50 
calories-from-carbs > 0.4 
calories-from-protein < 0.2 
meal-Type == "Breakfast" 
5% 5% 
4 revised  
BG-change > 50 
calories-from-carbs > 0.35 
calories-from-protein < 0.25 
meal-Type == "Breakfast" 
10% 6% 
5 
High fiber (over 15g) and 
moderate carb (20-40%) 
leads to low impact 
(lower than 50) 
BG-change < 50 
0.2 < calories-from-carbs < 0.4 
fiber > 15g 
3% 0% 
6 
In meals with fat around 
35-40% and low protein 
(under 10g), mild impact 
(this pattern seems to be 
only holding in some 
clusters, but not others) 
BG-change < 50 
0.35 < calories-from-fat < 0.4 
protein < 10g 
3% 1% 
6 revised  
BG-change < 50 
0.3 < calories-from-fat < 0.45 
protein < 10g 
6% 3% 
 TOTAL  24 
24% meals 
accounted 
for by 
observation
s 
14% of 
meals 
contradict 
an 
observation 
Supplementary Table 10: P1 Expert Observations (Post-Cluster) 
  
 Observati
on #  Text Description  Boolean Query 
%-meals in 
agreement  
%-meals  
with 
opposite 
glycemic 
impact  
1 
Higher fiber does not 
seem to have a positive 
impact on BG (meals 
with low fiber, lower than 
5g, have low glycemic 
impact)  
BG-change < 50 
fiber < 5g 29% 0% 
2 original 
High fiber (over 10g) and 
high fat (45-60%) 
together lead to low 
impact 
BG-change < 50 
fiber > 10g  
45% < calories-from-fat < 60% 
10% 3% 
2 revised  
BG-change < 50 
fiber > 10g  
40% < calories-from-fat < 65% 
14% 4% 
 TOTAL (72 meals) 31 meals accounted for 
43% meals 
accounted 
for by 
observation
s 
4% of 
meals 
contradict 
an 
observation 
Supplementary Table 11: P2 Expert Observations (Post-Cluster) 
  
 Observatio
n #  Text Description  Boolean Query 
%-meals in 
agreement  
%-meals  
with opposite 
glycemic 
impact  
1  
High proportion of fat (on 
average most meals have 
over 50%)  
calories-from-fat > 50%  64%  11%  
4  
The highest BG excursions 
(50 to 120) came from 
meals with higher total 
number of grams of carb 
(from 20 to 45g) and 
highest proportion of carbs 
and lower fiber (less than 
10g) even with high fat  
calories-from-carbs > median 
carbs > 20g fiber < 10g 
BG-change > 50 
20%  7%  
5  
Higher fat (over 40g) and 
higher fiber (over 10g) lead 
to lower glycemic 
excursion  
fat > 40g 
fiber > 10g 
BG-change < 50  
9%  3%  
6  
Higher fiber (over 10g) 
leads to lower excursion 
(particularly at dinner)  
Meal-Type == ”Dinner” 
fiber > 10g 
BG-change < 50  
25%  3%  
7  
Breakfast: proportion of 
carbs is the lowest, and 
protein is the highest, and 
BG excursion is moderate  
Meal-Type == ”Breakfast” 
calories-from-carbs < 
30%−quantile 
calories-from-protein > 
70%−quantile 
BG-change < 50  
16%  7%  
8  
Lunch: the highest BG 
change, grams of carbs is 
the highest (around 40g), 
proportion of carbs is the 
highest (30%), high fat 
(40%) and lowest protein 
(20%), and lower fiber 
(under 8g)  
Meal-Type == ”Lunch” 
calories-from-carbs > 30% 
calories-from-fat > 40% 
calories-from-protein < 20% 
fiber < 8g 
carbs > 40g 
BG-change > 50  
0%  0%  
 TOTAL  26 
59% meals 
accounted 
for by 
observations 
14% of meals 
contradict an 
observation 
Supplementary Table 12: P3 Expert Observations (Post-Cluster) 
  
Supplementary Figure 1. 
 
Parallel coordinate plots of behavioral-clinical self-monitoring data for all participants. Each line 
represents a single meal, and each vertical axis represents a behavioral or clinical variable 
(labeled at the bottom of each plot). The line color indicates the degree of glucose change, where 
red is highest and blue is lowest. These plots demonstrate the heterogeneity of behavioral-clinical 
patterns within and across participants. 
 
  
Supplementary Figure 2. 
 
Parallel coordinate plots of cluster means from all participants. Each line represents the mean 
values for a single cluster. Clustering was performed using the blood glucose with grams of 
macronutrients feature set, and clusters with fewer than 5 meals were excluded. We observe that 
each participant exhibits different personal behavioral-clinical phenotypes. 
